Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleNuclear Neurology

Iodine-123-N-ω-Fluoropropyl-2β-Carbomethoxy-3β-(4-Iodophenyl)Tropane SPECT in Healthy Controls and Early-Stage, Drug-Naive Parkinson's Disease

Gerrit Tissingh, Jan Booij, Paul Bergmans, Ania Winogrodzka, Anton G.M. Janssen, Eric A. van Royen, Johannes C. Stoof and Erik Ch. Wolters
Journal of Nuclear Medicine July 1998, 39 (7) 1143-1148;
Gerrit Tissingh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Booij
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Bergmans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ania Winogrodzka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anton G.M. Janssen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric A. van Royen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes C. Stoof
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Ch. Wolters
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 39, Issue 7
July 1, 1998
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Iodine-123-N-ω-Fluoropropyl-2β-Carbomethoxy-3β-(4-Iodophenyl)Tropane SPECT in Healthy Controls and Early-Stage, Drug-Naive Parkinson's Disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Iodine-123-N-ω-Fluoropropyl-2β-Carbomethoxy-3β-(4-Iodophenyl)Tropane SPECT in Healthy Controls and Early-Stage, Drug-Naive Parkinson's Disease
Gerrit Tissingh, Jan Booij, Paul Bergmans, Ania Winogrodzka, Anton G.M. Janssen, Eric A. van Royen, Johannes C. Stoof, Erik Ch. Wolters
Journal of Nuclear Medicine Jul 1998, 39 (7) 1143-1148;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Iodine-123-N-ω-Fluoropropyl-2β-Carbomethoxy-3β-(4-Iodophenyl)Tropane SPECT in Healthy Controls and Early-Stage, Drug-Naive Parkinson's Disease
Gerrit Tissingh, Jan Booij, Paul Bergmans, Ania Winogrodzka, Anton G.M. Janssen, Eric A. van Royen, Johannes C. Stoof, Erik Ch. Wolters
Journal of Nuclear Medicine Jul 1998, 39 (7) 1143-1148;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Long-term follow-up study of SWEDD patients with mild parkinsonian signs
  • An Anthropomorphic Phantom Study of Brain Dopamine Transporter SPECT Images Obtained Using Different SPECT/CT Devices and Collimators
  • Value of Semiquantitative Analysis for Clinical Reporting of 123I-2-{beta}-Carbomethoxy-3{beta}-(4-Iodophenyl)-N-(3-Fluoropropyl)Nortropane SPECT Studies
  • SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0
  • Validation of a Standardized Normalization Template for Statistical Parametric Mapping Analysis of 123I-FP-CIT Images
  • Quantification of Striatal Dopamine Transporters with 123I-FP-CIT SPECT Is Influenced by the Selective Serotonin Reuptake Inhibitor Paroxetine: A Double-Blind, Placebo-Controlled, Crossover Study in Healthy Control Subjects
  • Extended Studies of the Striatal Uptake of 99mTc-NC100697 in Healthy Volunteers
  • Is Iterative Reconstruction an Alternative to Filtered Backprojection in Routine Processing of Dopamine Transporter SPECT Studies?
  • Clinical Testing of an Optimized Software Solution for an Automated, Observer-Independent Evaluation of Dopamine Transporter SPECT Studies
  • Dopamine transporter SPECT in patients with mitochondrial disorders
  • Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: A comparison
  • Sensitivity and Specificity of 99mTc-TRODAT-1 SPECT Imaging in Differentiating Patients with Idiopathic Parkinson's Disease from Healthy Subjects
  • Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk
  • Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand
  • Google Scholar

More in this TOC Section

  • Crossed Cerebellar Diaschisis Due TO Intracranial Hematoma in Basal Ganglia or Thalamus
  • PET Quantification of Specific Binding of Carbon-11-Nicotine in Human Brain
  • Regional Cerebral Blood Flow Scintigraphy in Tick-Borne Encephalitis and Other Aseptic Meningoencephalitis
Show more Nuclear Neurology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire